| Application no. and date | 16758019.0 (espacenet) (Federated) (European Patent Register), 20160817 | | Patent/reg. no. and date | DK/EP 3337828, 20250827 | | Publication date | 20180627 | | Priority no. and date | US 201562206326 P, 20150818, US 201562264361 P, 20151208, US 201562270790 P, 20151222, US 201662291571 P, 20160205, US 201662311455 P, 20160322, US 201662367374 P, 20160727 | | EP pub. no. and date |
EP 3337828 20180627 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | | | Inventor | PORDY, Robert C., c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US,
MANVELIAN, Garen, c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US | | Representative | | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 3/06 (2006.01) , C07K 16/40 (2006.01) | | Title | ANTI-PCSK9 INHIBITORY ANTIBODIES FOR TREATING PATIENTS WITH HYPERLIPIDEMIA UNDERGOING LIPOPROTEIN APHERESIS | | Int. application no. | US2016047257 | | Int. publication no. | WO2017031151 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
